CLINICAL_TRIALS
trial_result
· 2009-12-03
Clinical Trial Update: Maintenance Intermittent Therapy for Symptomatic GERD Patients [Phase 2]
Summary
Phase 2 clinical trial update evaluating maintenance intermittent therapy for symptomatic Gastroesophageal Reflux Disease. The study results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Eisai Inc. | Conditions: Gastroesophageal Reflux Disease | Phase 2 | Status: COMPLETED | Results posted: 2009-12-03